Sansure Biotech Inc. (688289)

Overview

Sansure Biotech Inc. is a prominent player in the biotechnology industry, focusing primarily on the research, development, production, and sale of in vitro diagnostic reagents and instruments within China. Founded in 2008 and headquartered in Changsha, China, the company has established a solid reputation for offering an array of diagnostic solutions catering to various infectious diseases, including coronavirus and influenza virus, among others. Beyond its core offerings, Sansure also expands its expertise into the realms of drug research and development, electronic equipment manufacturing, trading, investment advisory, and medical research. Their commitment to innovation is further highlighted by their involvement in third-party medical testing and biotechnology development services.

Products and Services

Nucleic Acid Diagnostic Kits: These kits are designed for the detection of coronavirus, CoV-2, influenza virus, respiratory syncytial virus, and more. They offer a reliable solution for diagnosing viral infections through nucleic acid and multiple nucleic acid diagnostic techniques.

DNA Fluorescence and Nucleic Acid Diagnostic Kits: Targeted at respiratory tract infections, HPV infections, and reproductive tract infections, these kits utilize DNA fluorescence and nucleic acid diagnostics to ensure accurate detection and assessment of infections.

Nucleic Acid Tests and Fluorescence Diagnostic Kits for Blood-borne Infections: Sansure Biotech provides comprehensive diagnostics for blood-borne infections, employing nucleic acid tests and fluorescence diagnostics to identify infections accurately.

RNA Diagnostic Kits for Gastrointestinal Infections: These kits are specifically developed for the detection of gastrointestinal infections, leveraging RNA diagnostics to offer precise results.

Diagnostic Kits for Monkeypox, Epstein-Barr Virus, and Human Cytomegalovirus DNA: Sansure has expanded its diagnostic capabilities to include kits for emerging and re-emerging infections such as monkeypox, as well as for established concerns like Epstein-Barr virus and human cytomegalovirus.

Rapid Antigen Tests: Rapid antigen tests provided by Sansure offer quick and effective screening for various infectious diseases, facilitating immediate decision-making and intervention.

Nucleic Acid Extraction/Purification Kits and Instruments: These kits and instruments simplify the process of nucleic acid extraction or purification, essential for the accurate diagnosis of infectious diseases.

PCR Instruments: Including real-time quantitative thermal cyclers, portable molecule workstations, and real-time PCR systems, these instruments are crucial for the polymerase chain reaction (PCR) process, a staple in molecular diagnostics.

Aditional Services: Sansure Biotech also engages in the procurement and sale of raw materials, manufacture of instruments and electronic equipment, trading, investment advisory, and internet sales. Their commitment extends to third-party medical testing and biotechnology development services, highlighting their comprehensive approach to biotechnology.